Related Experiment Video
Updated: May 15, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
[Familial Mediterranean fever with pulmonary manifestations alone; early diagnosis with genetic analysis]
Fidan Sever1, Mustafa Sever, Salahattin Sanal
1Department of Chest Diseases, Faculty of Medicine, Sifa University, Izmir, Turkey. fidanyildiz@yahoo.com
Abstract:
Painful pleural effusion and fever are the only presenting clinical features in 5-10% of patients with familial Mediterranean fever (FMF). We report the results of genetic analysis that have confirmed the diagnosis of FMF in six patients who presented with fever and pleuritic pain alone. At time of presentation, all six patients received antibiotic treatment for suspected infectious etiology following routine laboratory and microbiologic evaluation. Gene analysis was performed when other diagnostic studies had failed to uncover the etiology and patients did not respond to conventional treatment. Mutation analysis for MEFV gene performed from genomic DNA by the direct DNA sequence method. Half of the patients were male. Five were older than 50, one was 33 years old. All of the patients had fever and pleuritic pain; none had the typical abdominal symptoms. Erythrocyte sedimentation rates and C-reactive protein levels were high. Pericardial effusion was discovered in three patients. Genetic analysis confirmed; R202Q/R202R, E148V/E148E, R314R, E474E, Q476Q, D510D, E148Q/E148E heterozygote polymorphisms with and M694V/M694V mutations were determined on the MEFV gene. In five patients an improvement has been observed with colchicine therapy. In one patient steroid treatment was needed because of no response to colchicine and clinical deterioration. Rapid improvement was observed in this case with steroid therapy. But after cessation of steroid therapy new flare developed that responded to new colchicine therapy. In patients who present with pleuritic chest pain and fever without an identifiable etiology, genetic analysis help making the diagnosis of FMF, especially in certain ethnic populations where FMF is relevant. This should help patients receive specific treatment without unnecessary delay. Thus, by making early diagnosis and timely delivery of treatment, disease progression is delayed and development of secondary amyloidosis avoided.
Insights
Familial Mediterranean Fever (FMF) can present solely with fever and pleuritic chest pain. Genetic analysis of the MEFV gene is crucial for diagnosing FMF in such cases, enabling timely treatment and preventing disease progression.
Area of Science:
- Genetics
- Rheumatology
- Internal Medicine
Background:
- Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
- Typical FMF presentation includes recurrent fever, serositis, and rash.
- Atypical presentations, such as isolated pleuritic pain and fever, can delay diagnosis.
Observation:
- Six patients presented with fever and pleuritic pain as their sole symptoms.
- Routine investigations and antibiotics were initially administered for suspected infection.
- Diagnosis was pursued via MEFV gene analysis due to lack of response to conventional treatment.
Findings:
- Genetic analysis confirmed FMF in all six patients.
- Specific MEFV gene mutations and polymorphisms were identified.
- Five patients responded well to colchicine therapy; one required initial steroid treatment.
Implications:
- Genetic testing for the MEFV gene is vital for diagnosing FMF in patients with unexplained fever and pleuritic chest pain.
- Early diagnosis and treatment with colchicine can prevent disease complications like secondary amyloidosis.
- This diagnostic approach is particularly relevant in populations with a high prevalence of FMF.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atypical Pneumonia
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
